205 related articles for article (PubMed ID: 17382628)
1. Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2.
Woo YJ; Panlilio CM; Cheng RK; Liao GP; Suarez EE; Atluri P; Chaudhry HW
J Thorac Cardiovasc Surg; 2007 Apr; 133(4):927-33. PubMed ID: 17382628
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure.
Woo YJ; Panlilio CM; Cheng RK; Liao GP; Atluri P; Hsu VM; Cohen JE; Chaudhry HW
Circulation; 2006 Jul; 114(1 Suppl):I206-13. PubMed ID: 16820573
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
4. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.
Tamamori-Adachi M; Takagi H; Hashimoto K; Goto K; Hidaka T; Koshimizu U; Yamada K; Goto I; Maejima Y; Isobe M; Nakayama KI; Inomata N; Kitajima S
Cardiovasc Res; 2008 Nov; 80(2):181-90. PubMed ID: 18596061
[TBL] [Abstract][Full Text] [Related]
7. Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure.
Berry MF; Pirolli TJ; Jayasankar V; Morine KJ; Moise MA; Fisher O; Gardner TJ; Patterson PH; Woo YJ
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):866-75. PubMed ID: 15573071
[TBL] [Abstract][Full Text] [Related]
8. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
[TBL] [Abstract][Full Text] [Related]
9. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts.
Kutschka I; Kofidis T; Chen IY; von Degenfeld G; Zwierzchoniewska M; Hoyt G; Arai T; Lebl DR; Hendry SL; Sheikh AY; Cooke DT; Connolly A; Blau HM; Gambhir SS; Robbins RC
Circulation; 2006 Jul; 114(1 Suppl):I174-80. PubMed ID: 16820569
[TBL] [Abstract][Full Text] [Related]
11. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Berry MF; Burdick J; Bhalla RC; Sharma RV; Gardner TJ; Sweeney HL
Circulation; 2004 Sep; 110(11 Suppl 1):II180-6. PubMed ID: 15364860
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Chatterjee S; Berry MF; Burdick J; Gardner TJ; Sweeney HL
Circulation; 2003 Sep; 108 Suppl 1():II230-6. PubMed ID: 12970238
[TBL] [Abstract][Full Text] [Related]
14. Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.
Atluri P; Liao GP; Panlilio CM; Hsu VM; Leskowitz MJ; Morine KJ; Cohen JE; Berry MF; Suarez EE; Murphy DA; Lee WM; Gardner TJ; Sweeney HL; Woo YJ
Ann Thorac Surg; 2006 May; 81(5):1728-36. PubMed ID: 16631663
[TBL] [Abstract][Full Text] [Related]
15. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
[TBL] [Abstract][Full Text] [Related]
16. Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy.
Bian J; Popovic ZB; Benejam C; Kiedrowski M; Rodriguez LL; Penn MS
Circ Res; 2007 Jun; 100(11):1626-33. PubMed ID: 17495229
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs.
Uwatoku T; Ito K; Abe K; Oi K; Hizume T; Sunagawa K; Shimokawa H
Coron Artery Dis; 2007 Aug; 18(5):397-404. PubMed ID: 17627190
[TBL] [Abstract][Full Text] [Related]
18. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
19. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
